Cetirizine Hydrochloride Market - Size, Share, Trends, and Forecast, 2022 - 2028

Cetirizine Hydrochloride Market - Size, Share, Trends, and Forecast, 2022 - 2028

Cetirizine hydrochloride is a second-generation histamine H1 antagonist that is effective in treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Cetirizine does not cause drowsiness or anticholinergic side effects opposed to conventional antihistamines. Cetirizine is available in various forms such as regular and chewable tablets, capsules, and solutions.
Market Dynamics
Increasing prevalence of allergic conditions in children and adult population is major factor driving growth of the cetirizine hydrochloride market. According to the National Health Interview Survey (NHIS), 2014, around 8.4% of children under the age of 18 suffered from hay fever, 10% from respiratory allergies, 5.4% from food allergies, and 11.6% from skin allergies in the U.S. Furthermore, allergic conjunctivitis imposes economic and social burden on the affected population, thereby increasing the adoption of efficient treatment to curb the increasing healthcare costs. According to the Department of Ophthalmology and Visual Sciences, University of Wisconsin, 2013, an estimated 6 million people are affected by bacterial conjunctivitis, annually in the U.S. The total expenditure in treatment of the disease was reported around US $377 million to US$ 857 million, annually.
Key features of the study:

This report provides in-depth analysis of the cetirizine hydrochloride market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global cetirizine hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Johnson and Johnson, Mylan, Inc., Nicox S.A., Strides Shasun, Apotex, Inc., Teva UK Limited, Aurobindo Pharma Limited, Jubilant Life Sciences, Tris Pharma, Inc., and Cipla Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global cetirizine hydrochloride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cetirizine hydrochloride market

Detailed Segmentation:

Global Cetirizine Hydrochloride Market, By Dosage Form:

Tablet
Syrup
Solution

Global Cetirizine Hydrochloride Market, By Age Group:

Adult
Pediatric

Global Cetirizine Hydrochloride Market, By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

Global Cetirizine Hydrochloride Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Cetirizine Hydrochloride Market, By Geography:

North America

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

U.S.
Canada

Latin America

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe

Asia Pacific

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

GCC
Israel
Rest of Middle East

Africa

By Dosage Form:

Tablet
Syrup
Solution

By Age Group:

Adult
Pediatric

By Application:

Allergic Rhinitis
Allergic Conjunctivitis
Eczema
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Country:

South Africa
Central Africa
North Africa

Company Profiles

Johnson and Johnson*

Company Overview
Product Portfolio
Financial Performance
Recent Developments
Market Strategies

Mylan, Inc.
Nicox S.A.
Strides Shasun
Apotex, Inc.
Teva UK Limited
Aurobindo Pharma Limited
Jubiliant Life Sciences
Tris Pharma, Inc.
Cipla Ltd.

“*” marked represents similar segmentation in other categories in the respective section.